Initial adoption of clinical pathways grew from payers mandating their use with individual providers, but there is now greater interest from accountable care organizations and others to use pathways to reduce variation and cost while improving outcomes, explained Robert Dubois, MD, PhD, chief science officer and executive vice president of the National Pharmaceutical Council.
Initial adoption of clinical pathways grew from payers mandating their use with individual providers, but there is now greater interest from accountable care organizations and others to use pathways to reduce variation and cost while improving outcomes, explained Robert Dubois, MD, PhD, chief science officer and executive vice president of the National Pharmaceutical Council.
Transcript (slightly modified)
How are pathways expanding into different healthcare delivery systems, such as accountable care organizations and integrated delivery networks?
When we began this work, we were quite aware of interest in oncology and quite aware of payers working with individual providers to say, “Ok, these are the pathways that we would mutually want to use.”
What we’re also finding is that there is interest beyond the payer being the group that says “These pathways would be good.” As physicians and physician groups and integrated delivery systems take on risk for managing patients over a longitudinal aspect of care, we’re finding greater interested by accountable care organizations, by these integrated delivery systems, to incorporate clinical pathways into what they do and how they do it. Not because it’s mandated by the payer, but because they, too, want to bring some of the same principles of reducing variation, improving patient outcomes, and reducing costs, just like the payers had.
So we’re going to see an evolution, over time, of much more broader pathways adoption.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More